A1 Urine Drug Testing Delray Beach, FL - 33484

A1 Urine Drug Testing is categorized under Drug Detection Service and Equipment in Delray Beach, FL .

A1 Urine Drug Testing was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Drug Detection Service and Equipment business, which does work in the B2C market, and is classified as a Drug Detection Service and Equipment, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact Barry Seidman, Owner at the company’s single location by writing to 5258 Linton Boulevard # 205, Delray Beach, Florida FL 33484 or by phoning (561) 381-4920. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: A1 Urine Drug Testing
Contact Person: Barry Seidman, Owner
Address: 5258 Linton Boulevard # 205, Delray Beach, Florida 33484
Phone Number: (561) 381-4920
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drug Detection Service and Equipment
SIC Code: 8071
NAICS Code: 6215110
Share This Business:

A1 Urine Drug Testing was started in 0 to provide professional Drug Detection Service and Equipment under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Barry Seidman, Owner for inquiries that concern A1 Urine Drug Testing by calling the company number (561) 381-4920, as your correspondence is most welcome. Additionally, the physical location of the single location of A1 Urine Drug Testing can be found at the coordinates 26.439264,-80.126046 as well as the street address 5258 Linton Boulevard # 205 in Delray Beach, Florida 33484.

For its online presence, you may visit A1 Urine Drug Testing’s website at and engage with its social media outlets through on Twitter and on Facebook.